Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1985 May;85(1):3–5. doi: 10.1111/j.1476-5381.1985.tb08823.x

Adenosine potentiates immunological histamine release from rat mast cells by a novel cyclic AMP-independent cell-surface action.

M K Church, P J Hughes
PMCID: PMC1916757  PMID: 2411320

Abstract

Adenosine enhanced histamine release and prolonged the adenosine 3':5'-cyclic monophosphate (cyclic AMP) response in purified rat peritoneal mast cells following immunological challenge. The effect on the cyclic AMP response, which was blocked by 8-phenyltheophylline, probably results from an interaction with A2-purinoceptors. Enhancement of histamine release showed different characteristics. It was not inhibited by dipyridamole or hexobendine, thereby indicating an action at the cell surface. However, the relative potencies of adenosine analogues and nucleotides, together with the observation that this effect was not antagonized by 8-phenyltheophylline or theophylline, suggest that it is not mediated by a previously recognised purinoceptor. Thus, enhancement of histamine release may represent a novel cell surface action of adenosine which is independent of its effects on adenylate cyclase.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Church M. K., Holgate S. T., Hughes P. J. Adenosine inhibits and potentiates IgE-dependent histamine release from human basophils by an A2-receptor mediated mechanism. Br J Pharmacol. 1983 Dec;80(4):719–726. doi: 10.1111/j.1476-5381.1983.tb10063.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Griffith S. G., Meghji P., Moody C. J., Burnstock G. 8-phenyltheophylline: a potent P1-purinoceptor antagonist. Eur J Pharmacol. 1981 Oct 15;75(1):61–64. doi: 10.1016/0014-2999(81)90346-0. [DOI] [PubMed] [Google Scholar]
  3. Holgate S. T., Lewis R. A., Austen K. F. Role of adenylate cyclase in immunologic release of mediators from rat mast cells: agonist and antagonist effects of purine- and ribose-modified adenosine analogs. Proc Natl Acad Sci U S A. 1980 Nov;77(11):6800–6804. doi: 10.1073/pnas.77.11.6800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hughes P. J., Holgate S. T., Roath S., Church M. K. The relationship between cyclic AMP changes and histamine release from basophil-rich human leucocytes. Biochem Pharmacol. 1983 Sep 1;32(17):2557–2563. doi: 10.1016/0006-2952(83)90018-7. [DOI] [PubMed] [Google Scholar]
  5. Londos C., Wolff J. Two distinct adenosine-sensitive sites on adenylate cyclase. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5482–5486. doi: 10.1073/pnas.74.12.5482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Turnheim K., Plank B., Kolassa N. Inhibition of adenosine uptake in human erythrocytes by adenosine-5'-carboxamides, xylosyladenine, dipyridamole, hexobendine, and p-nitrobenzylthioguanosine. Biochem Pharmacol. 1978;27(18):2191–2197. doi: 10.1016/0006-2952(78)90076-x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES